BOT-502

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameBOT-502
Drug Alias NameBOT-502
ClassificationRadiation-emitting productsBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLiver CirrhosisBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiorion Technologies
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiorion Technologies
Active IndicationsN/A
Inactive IndicationsLiver CirrhosisBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A